Novo Nordisk

Explore the topic

Monday, 27 April 2026

1 day ago

Economic toll of obesity in PH drives care shift

Obesity and its related diseases are imposing a heavy economic toll on the Philippines, reshaping both health-care priorities and demand for new treatments such as semaglutide.

11 Sep 2025

5:17PM

Watsons, Novo Nordisk join forces to fight rising obesity in PH

Despite widespread misconceptions, obesity is a chronic, relapsing disease that affects nearly 40 percent of the population

EDITORS' PICK

DivinaLaw marks 20 years with star-studded gathering of PH power players

18 Apr 2026

1:34AM

No flight cancellations, but delays likely during ASEAN meet

23 Apr 2026

10:31AM

No slowdown: Megaworld ramps up township developments

22 Apr 2026

11:57AM

INSIDER VIEW | From campaigns to action: DepEd tackles bullying

17 Apr 2026

6:48AM

INSIDER VIEW | WESM suspension is a symbolic fix, not a real solution

11 Apr 2026

6:32AM

LIVES WELL LIVED | 'Polly' Nazareno and PLDT’s transformation

10 Apr 2026

8:19AM

INSIDER VIEW | Longevity tech may reshape how we live and age

7 Apr 2026

9:01AM

San Miguel, MPTC cut toll fees to ease fuel-driven price pressure

22 Mar 2026

3:08PM

Go to Homepage Back to Top

Insight to the one percent